
AI
Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 billion in a Series C funding round.
You're reading a preview. The full article is published by TechCrunch on their website.
Read the full story on TechCrunch
